Full Text of HB1366 95th General Assembly
HB1366ham001 95TH GENERAL ASSEMBLY
|
Registration and Regulation Committee
Filed: 3/14/2007
|
|
09500HB1366ham001 |
|
LRB095 04320 RAS 33506 a |
|
| 1 |
| AMENDMENT TO HOUSE BILL 1366
| 2 |
| AMENDMENT NO. ______. Amend House Bill 1366 by replacing | 3 |
| everything after the enacting clause with the following:
| 4 |
| "Section 5. The Illinois Optometric Practice Act of 1987 is | 5 |
| amended by changing Sections 15.1 and 16 as follows:
| 6 |
| (225 ILCS 80/15.1)
| 7 |
| (Section scheduled to be repealed on January 1, 2017)
| 8 |
| Sec. 15.1. Diagnostic and therapeutic authority.
| 9 |
| (a) For purposes of the Act, "ocular pharmaceutical
agents" | 10 |
| means topical anesthetics, topical mydriatics, topical
| 11 |
| cycloplegics, topical miotics and mydriatic reversing agents , | 12 |
| topical anti-infective agents,
topical anti-allergy agents,
| 13 |
| topical
anti-glaucoma agents (except oral carbonic anhydrase | 14 |
| inhibitors, which may be prescribed only in a quantity | 15 |
| sufficient to provide treatment for up to 72 hours) , topical
| 16 |
| anti-inflammatory agents (except oral steroids) , topical
|
|
|
|
09500HB1366ham001 |
- 2 - |
LRB095 04320 RAS 33506 a |
|
| 1 |
| anesthetic
agents, over-the-counter agents, and
non-narcotic | 2 |
| oral analgesic
agents ,
and mydriatic reversing
agents when used | 3 |
| for diagnostic or therapeutic purposes . | 4 |
| (a-5) Ocular pharmaceutical agents administered by | 5 |
| injection may be used only for the treatment of anaphylaxis. | 6 |
| (a-10) Oral pharmaceutical agents may be prescribed for a | 7 |
| child under 5 years of age only in consultation with a | 8 |
| physician licensed to practice medicine in all its branches. | 9 |
| (a-15) The authority to prescribe a Schedule III, IV, or V | 10 |
| controlled substance shall include only analgesic agents in a | 11 |
| quantity sufficient to provide treatment for up to 72 hours. | 12 |
| The prescription of a Schedule II controlled substance is | 13 |
| prohibited.
| 14 |
| (b) A licensed optometrist may remove superficial foreign | 15 |
| bodies from the human eye and adnexa and may give orders for | 16 |
| patient care to a nurse licensed to practice under Illinois | 17 |
| law. | 18 |
|
(c) An optometrist's license shall be revoked or suspended | 19 |
| by the Department
upon recommendation of the Board based upon | 20 |
| either of the
following causes: | 21 |
| (1) grave or repeated misuse of any ocular
| 22 |
| pharmaceutical agent; and | 23 |
| (2) the use of any agent or procedure in the course of | 24 |
| optometric practice
by an optometrist not properly | 25 |
| authorized under this Act. | 26 |
| (d) The Secretary of Financial and Professional Regulation |
|
|
|
09500HB1366ham001 |
- 3 - |
LRB095 04320 RAS 33506 a |
|
| 1 |
| shall notify
the Director of Public Health as to the categories | 2 |
| of ocular
pharmaceutical agents permitted for use by an | 3 |
| optometrist. The Director of Public Health shall in turn
notify | 4 |
| every licensed pharmacist in the State of the categories of | 5 |
| ocular
pharmaceutical agents that can be utilized and | 6 |
| prescribed by an optometrist.
| 7 |
| (Source: P.A. 94-787, eff. 5-19-06 .)
| 8 |
| (225 ILCS 80/16) (from Ch. 111, par. 3916)
| 9 |
| (Section scheduled to be repealed on January 1, 2017)
| 10 |
| Sec. 16. Renewal, reinstatement or restoration of | 11 |
| licenses; military
service. The expiration date and renewal | 12 |
| period for each license issued under this Act shall be set by | 13 |
| rule.
| 14 |
| All renewal applicants shall provide proof of having met | 15 |
| the requirements
of continuing education set forth in the rules | 16 |
| of the Department. The
Department shall, by rule, provide for | 17 |
| an orderly process for the
reinstatement of licenses which have | 18 |
| not been renewed due to failure to
meet the continuing | 19 |
| education requirements. The continuing education
requirement | 20 |
| may be waived for such good cause, including but not limited to
| 21 |
| illness or hardship, as defined by rules
of the Department.
| 22 |
| The Department shall establish by rule a means for the | 23 |
| verification of
completion of the continuing education | 24 |
| required by this Section. This
verification may be accomplished | 25 |
| through audits of records maintained by
registrants; by |
|
|
|
09500HB1366ham001 |
- 4 - |
LRB095 04320 RAS 33506 a |
|
| 1 |
| requiring the filing of continuing education certificates
with | 2 |
| the Department; or by other means established by the | 3 |
| Department.
| 4 |
| Any licensee seeking renewal of his or her license during | 5 |
| the renewal cycle beginning April 1, 2008 must first complete a | 6 |
| tested educational course in the use of oral pharmaceutical | 7 |
| agents for the management of ocular conditions, as approved by | 8 |
| Board.
| 9 |
| Any optometrist who has permitted his or her license to | 10 |
| expire or who has
had his or her license on inactive status may | 11 |
| have his or her license restored
by making application to the | 12 |
| Department and filing proof acceptable to the
Department of his | 13 |
| or her fitness to have his or her license restored and by
| 14 |
| paying the required fees. Such proof of fitness may include | 15 |
| evidence
certifying to active lawful practice in another | 16 |
| jurisdiction and must include
proof of the completion of the | 17 |
| continuing education requirements specified in
the rules for | 18 |
| the preceding license renewal period that has been completed | 19 |
| during the 2 years prior to the
application for license | 20 |
| restoration.
| 21 |
| The Department shall determine, by an evaluation program | 22 |
| established by
rule, his or her fitness for restoration of his | 23 |
| or her license and
shall establish procedures and requirements | 24 |
| for such restoration.
| 25 |
| However, any optometrist whose license expired while he or | 26 |
| she was (1) in
Federal Service on active duty with the Armed |
|
|
|
09500HB1366ham001 |
- 5 - |
LRB095 04320 RAS 33506 a |
|
| 1 |
| Forces of the United States,
or the State Militia called into | 2 |
| service or training, or (2) in training or
education under the | 3 |
| supervision of the United States preliminary to
induction into | 4 |
| the military service, may have his or her license restored
| 5 |
| without paying any lapsed renewal fees if within 2 years after | 6 |
| honorable
termination of such service, training, or education, | 7 |
| he or she furnishes
the Department with satisfactory evidence | 8 |
| to the effect that he or she has
been so engaged and that his or | 9 |
| her service, training, or education has been
so terminated. | 10 |
| All licenses without "Therapeutic Certification" on March | 11 |
| 31, 2006 shall be placed on non-renewed status and may only be | 12 |
| renewed after the licensee meets those requirements | 13 |
| established by the Department that may not be waived.
| 14 |
| (Source: P.A. 94-787, eff. 5-19-06.)
| 15 |
| Section 10. The Illinois Controlled Substances Act is | 16 |
| amended by changing Sections 102 and 103 as follows: | 17 |
| (720 ILCS 570/102) (from Ch. 56 1/2, par. 1102) | 18 |
| Sec. 102. Definitions. As used in this Act, unless the | 19 |
| context
otherwise requires:
| 20 |
| (a) "Addict" means any person who habitually uses any drug, | 21 |
| chemical,
substance or dangerous drug other than alcohol so as | 22 |
| to endanger the public
morals, health, safety or welfare or who | 23 |
| is so far addicted to the use of a
dangerous drug or controlled | 24 |
| substance other than alcohol as to have lost
the power of self |
|
|
|
09500HB1366ham001 |
- 6 - |
LRB095 04320 RAS 33506 a |
|
| 1 |
| control with reference to his addiction.
| 2 |
| (b) "Administer" means the direct application of a | 3 |
| controlled
substance, whether by injection, inhalation, | 4 |
| ingestion, or any other
means, to the body of a patient, | 5 |
| research subject, or animal (as
defined by the Humane | 6 |
| Euthanasia in Animal Shelters Act) by:
| 7 |
| (1) a practitioner (or, in his presence, by his | 8 |
| authorized agent),
| 9 |
| (2) the patient or research subject at the lawful | 10 |
| direction of the
practitioner, or
| 11 |
| (3) a euthanasia technician as defined by the Humane | 12 |
| Euthanasia in
Animal Shelters Act.
| 13 |
| (c) "Agent" means an authorized person who acts on behalf | 14 |
| of or at
the direction of a manufacturer, distributor, or | 15 |
| dispenser. It does not
include a common or contract carrier, | 16 |
| public warehouseman or employee of
the carrier or warehouseman.
| 17 |
| (c-1) "Anabolic Steroids" means any drug or hormonal | 18 |
| substance,
chemically and pharmacologically related to | 19 |
| testosterone (other than
estrogens, progestins, and | 20 |
| corticosteroids) that promotes muscle growth,
and includes:
| 21 |
| (i) boldenone,
| 22 |
| (ii) chlorotestosterone,
| 23 |
| (iii) chostebol,
| 24 |
| (iv) dehydrochlormethyltestosterone,
| 25 |
| (v) dihydrotestosterone,
| 26 |
| (vi) drostanolone,
|
|
|
|
09500HB1366ham001 |
- 7 - |
LRB095 04320 RAS 33506 a |
|
| 1 |
| (vii) ethylestrenol,
| 2 |
| (viii) fluoxymesterone,
| 3 |
| (ix) formebulone,
| 4 |
| (x) mesterolone,
| 5 |
| (xi) methandienone,
| 6 |
| (xii) methandranone,
| 7 |
| (xiii) methandriol,
| 8 |
| (xiv) methandrostenolone,
| 9 |
| (xv) methenolone,
| 10 |
| (xvi) methyltestosterone,
| 11 |
| (xvii) mibolerone,
| 12 |
| (xviii) nandrolone,
| 13 |
| (xix) norethandrolone,
| 14 |
| (xx) oxandrolone,
| 15 |
| (xxi) oxymesterone,
| 16 |
| (xxii) oxymetholone,
| 17 |
| (xxiii) stanolone,
| 18 |
| (xxiv) stanozolol,
| 19 |
| (xxv) testolactone,
| 20 |
| (xxvi) testosterone,
| 21 |
| (xxvii) trenbolone, and
| 22 |
| (xxviii) any salt, ester, or isomer of a drug or | 23 |
| substance described
or listed in this paragraph, if | 24 |
| that salt, ester, or isomer promotes muscle
growth.
| 25 |
| Any person who is otherwise lawfully in possession of an | 26 |
| anabolic
steroid, or who otherwise lawfully manufactures, |
|
|
|
09500HB1366ham001 |
- 8 - |
LRB095 04320 RAS 33506 a |
|
| 1 |
| distributes, dispenses,
delivers, or possesses with intent to | 2 |
| deliver an anabolic steroid, which
anabolic steroid is | 3 |
| expressly intended for and lawfully allowed to be
administered | 4 |
| through implants to livestock or other nonhuman species, and
| 5 |
| which is approved by the Secretary of Health and Human Services | 6 |
| for such
administration, and which the person intends to | 7 |
| administer or have
administered through such implants, shall | 8 |
| not be considered to be in
unauthorized possession or to | 9 |
| unlawfully manufacture, distribute, dispense,
deliver, or | 10 |
| possess with intent to deliver such anabolic steroid for
| 11 |
| purposes of this Act.
| 12 |
| (d) "Administration" means the Drug Enforcement | 13 |
| Administration,
United States Department of Justice, or its | 14 |
| successor agency.
| 15 |
| (e) "Control" means to add a drug or other substance, or | 16 |
| immediate
precursor, to a Schedule under Article II of this Act | 17 |
| whether by
transfer from another Schedule or otherwise.
| 18 |
| (f) "Controlled Substance" means a drug, substance, or | 19 |
| immediate
precursor in the Schedules of Article II of this Act.
| 20 |
| (g) "Counterfeit substance" means a controlled substance, | 21 |
| which, or
the container or labeling of which, without | 22 |
| authorization bears the
trademark, trade name, or other | 23 |
| identifying mark, imprint, number or
device, or any likeness | 24 |
| thereof, of a manufacturer, distributor, or
dispenser other | 25 |
| than the person who in fact manufactured, distributed,
or | 26 |
| dispensed the substance.
|
|
|
|
09500HB1366ham001 |
- 9 - |
LRB095 04320 RAS 33506 a |
|
| 1 |
| (h) "Deliver" or "delivery" means the actual, constructive | 2 |
| or
attempted transfer of possession of a controlled substance, | 3 |
| with or
without consideration, whether or not there is an | 4 |
| agency relationship.
| 5 |
| (i) "Department" means the Illinois Department of Human | 6 |
| Services (as
successor to the Department of Alcoholism and | 7 |
| Substance Abuse) or its successor agency.
| 8 |
| (j) "Department of State Police" means the Department of | 9 |
| State
Police of the State of Illinois or its successor agency.
| 10 |
| (k) "Department of Corrections" means the Department of | 11 |
| Corrections
of the State of Illinois or its successor agency.
| 12 |
| (l) "Department of Professional Regulation" means the | 13 |
| Department
of Professional Regulation of the State of Illinois | 14 |
| or its successor agency.
| 15 |
| (m) "Depressant" or "stimulant substance" means:
| 16 |
| (1) a drug which contains any quantity of (i) | 17 |
| barbituric acid or
any of the salts of barbituric acid | 18 |
| which has been designated as habit
forming under section | 19 |
| 502 (d) of the Federal Food, Drug, and Cosmetic
Act (21 | 20 |
| U.S.C. 352 (d)); or
| 21 |
| (2) a drug which contains any quantity of (i) | 22 |
| amphetamine or
methamphetamine and any of their optical | 23 |
| isomers; (ii) any salt of
amphetamine or methamphetamine or | 24 |
| any salt of an optical isomer of
amphetamine; or (iii) any | 25 |
| substance which the Department, after
investigation, has | 26 |
| found to be, and by rule designated as, habit forming
|
|
|
|
09500HB1366ham001 |
- 10 - |
LRB095 04320 RAS 33506 a |
|
| 1 |
| because of its depressant or stimulant effect on the | 2 |
| central nervous
system; or
| 3 |
| (3) lysergic acid diethylamide; or
| 4 |
| (4) any drug which contains any quantity of a substance | 5 |
| which the
Department, after investigation, has found to | 6 |
| have, and by rule
designated as having, a potential for | 7 |
| abuse because of its depressant or
stimulant effect on the | 8 |
| central nervous system or its hallucinogenic
effect.
| 9 |
| (n) (Blank).
| 10 |
| (o) "Director" means the Director of the Department of | 11 |
| State Police or
the Department of Professional Regulation or | 12 |
| his designated agents.
| 13 |
| (p) "Dispense" means to deliver a controlled substance to | 14 |
| an
ultimate user or research subject by or pursuant to the | 15 |
| lawful order of
a prescriber, including the prescribing, | 16 |
| administering, packaging,
labeling, or compounding necessary | 17 |
| to prepare the substance for that
delivery.
| 18 |
| (q) "Dispenser" means a practitioner who dispenses.
| 19 |
| (r) "Distribute" means to deliver, other than by | 20 |
| administering or
dispensing, a controlled substance.
| 21 |
| (s) "Distributor" means a person who distributes.
| 22 |
| (t) "Drug" means (1) substances recognized as drugs in the | 23 |
| official
United States Pharmacopoeia, Official Homeopathic | 24 |
| Pharmacopoeia of the
United States, or official National | 25 |
| Formulary, or any supplement to any
of them; (2) substances | 26 |
| intended for use in diagnosis, cure, mitigation,
treatment, or |
|
|
|
09500HB1366ham001 |
- 11 - |
LRB095 04320 RAS 33506 a |
|
| 1 |
| prevention of disease in man or animals; (3) substances
(other | 2 |
| than food) intended to affect the structure of any function of
| 3 |
| the body of man or animals and (4) substances intended for use | 4 |
| as a
component of any article specified in clause (1), (2), or | 5 |
| (3) of this
subsection. It does not include devices or their | 6 |
| components, parts, or
accessories.
| 7 |
| (t-5) "Euthanasia agency" means
an entity certified by the | 8 |
| Department of Professional Regulation for the
purpose of animal | 9 |
| euthanasia that holds an animal control facility license or
| 10 |
| animal
shelter license under the Animal Welfare Act. A | 11 |
| euthanasia agency is
authorized to purchase, store, possess, | 12 |
| and utilize Schedule II nonnarcotic and
Schedule III | 13 |
| nonnarcotic drugs for the sole purpose of animal euthanasia.
| 14 |
| (t-10) "Euthanasia drugs" means Schedule II or Schedule III | 15 |
| substances
(nonnarcotic controlled substances) that are used | 16 |
| by a euthanasia agency for
the purpose of animal euthanasia.
| 17 |
| (u) "Good faith" means the prescribing or dispensing of a | 18 |
| controlled
substance by a practitioner in the regular course of | 19 |
| professional
treatment to or for any person who is under his | 20 |
| treatment for a
pathology or condition other than that | 21 |
| individual's physical or
psychological dependence upon or | 22 |
| addiction to a controlled substance,
except as provided herein: | 23 |
| and application of the term to a pharmacist
shall mean the | 24 |
| dispensing of a controlled substance pursuant to the
| 25 |
| prescriber's order which in the professional judgment of the | 26 |
| pharmacist
is lawful. The pharmacist shall be guided by |
|
|
|
09500HB1366ham001 |
- 12 - |
LRB095 04320 RAS 33506 a |
|
| 1 |
| accepted professional
standards including, but not limited to | 2 |
| the following, in making the
judgment:
| 3 |
| (1) lack of consistency of doctor-patient | 4 |
| relationship,
| 5 |
| (2) frequency of prescriptions for same drug by one | 6 |
| prescriber for
large numbers of patients,
| 7 |
| (3) quantities beyond those normally prescribed,
| 8 |
| (4) unusual dosages,
| 9 |
| (5) unusual geographic distances between patient, | 10 |
| pharmacist and
prescriber,
| 11 |
| (6) consistent prescribing of habit-forming drugs.
| 12 |
| (u-1) "Home infusion services" means services provided by a | 13 |
| pharmacy in
compounding solutions for direct administration to | 14 |
| a patient in a private
residence, long-term care facility, or | 15 |
| hospice setting by means of parenteral,
intravenous, | 16 |
| intramuscular, subcutaneous, or intraspinal infusion.
| 17 |
| (v) "Immediate precursor" means a substance:
| 18 |
| (1) which the Department has found to be and by rule | 19 |
| designated as
being a principal compound used, or produced | 20 |
| primarily for use, in the
manufacture of a controlled | 21 |
| substance;
| 22 |
| (2) which is an immediate chemical intermediary used or | 23 |
| likely to
be used in the manufacture of such controlled | 24 |
| substance; and
| 25 |
| (3) the control of which is necessary to prevent, | 26 |
| curtail or limit
the manufacture of such controlled |
|
|
|
09500HB1366ham001 |
- 13 - |
LRB095 04320 RAS 33506 a |
|
| 1 |
| substance.
| 2 |
| (w) "Instructional activities" means the acts of teaching, | 3 |
| educating
or instructing by practitioners using controlled | 4 |
| substances within
educational facilities approved by the State | 5 |
| Board of Education or
its successor agency.
| 6 |
| (x) "Local authorities" means a duly organized State, | 7 |
| County or
Municipal peace unit or police force.
| 8 |
| (y) "Look-alike substance" means a substance, other than a | 9 |
| controlled
substance which (1) by overall dosage unit | 10 |
| appearance, including shape,
color, size, markings or lack | 11 |
| thereof, taste, consistency, or any other
identifying physical | 12 |
| characteristic of the substance, would lead a reasonable
person | 13 |
| to believe that the substance is a controlled substance, or (2) | 14 |
| is
expressly or impliedly represented to be a controlled | 15 |
| substance or is
distributed under circumstances which would | 16 |
| lead a reasonable person to
believe that the substance is a | 17 |
| controlled substance. For the purpose of
determining whether | 18 |
| the representations made or the circumstances of the
| 19 |
| distribution would lead a reasonable person to believe the | 20 |
| substance to be
a controlled substance under this clause (2) of | 21 |
| subsection (y), the court or
other authority may consider the | 22 |
| following factors in addition to any other
factor that may be | 23 |
| relevant:
| 24 |
| (a) statements made by the owner or person in control | 25 |
| of the substance
concerning its nature, use or effect;
| 26 |
| (b) statements made to the buyer or recipient that the |
|
|
|
09500HB1366ham001 |
- 14 - |
LRB095 04320 RAS 33506 a |
|
| 1 |
| substance may
be resold for profit;
| 2 |
| (c) whether the substance is packaged in a manner | 3 |
| normally used for the
illegal distribution of controlled | 4 |
| substances;
| 5 |
| (d) whether the distribution or attempted distribution | 6 |
| included an
exchange of or demand for money or other | 7 |
| property as consideration, and
whether the amount of the | 8 |
| consideration was substantially greater than the
| 9 |
| reasonable retail market value of the substance.
| 10 |
| Clause (1) of this subsection (y) shall not apply to a | 11 |
| noncontrolled
substance in its finished dosage form that was | 12 |
| initially introduced into
commerce prior to the initial | 13 |
| introduction into commerce of a controlled
substance in its | 14 |
| finished dosage form which it may substantially resemble.
| 15 |
| Nothing in this subsection (y) prohibits the dispensing or | 16 |
| distributing
of noncontrolled substances by persons authorized | 17 |
| to dispense and
distribute controlled substances under this | 18 |
| Act, provided that such action
would be deemed to be carried | 19 |
| out in good faith under subsection (u) if the
substances | 20 |
| involved were controlled substances.
| 21 |
| Nothing in this subsection (y) or in this Act prohibits the | 22 |
| manufacture,
preparation, propagation, compounding, | 23 |
| processing, packaging, advertising
or distribution of a drug or | 24 |
| drugs by any person registered pursuant to
Section 510 of the | 25 |
| Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360).
| 26 |
| (y-1) "Mail-order pharmacy" means a pharmacy that is |
|
|
|
09500HB1366ham001 |
- 15 - |
LRB095 04320 RAS 33506 a |
|
| 1 |
| located in a state
of the United States, other than Illinois, | 2 |
| that delivers, dispenses or
distributes, through the United | 3 |
| States Postal Service or other common
carrier, to Illinois | 4 |
| residents, any substance which requires a prescription.
| 5 |
| (z) "Manufacture" means the production, preparation, | 6 |
| propagation,
compounding, conversion or processing of a | 7 |
| controlled substance other than methamphetamine, either
| 8 |
| directly or indirectly, by extraction from substances of | 9 |
| natural origin,
or independently by means of chemical | 10 |
| synthesis, or by a combination of
extraction and chemical | 11 |
| synthesis, and includes any packaging or
repackaging of the | 12 |
| substance or labeling of its container, except that
this term | 13 |
| does not include:
| 14 |
| (1) by an ultimate user, the preparation or compounding | 15 |
| of a
controlled substance for his own use; or
| 16 |
| (2) by a practitioner, or his authorized agent under | 17 |
| his
supervision, the preparation, compounding, packaging, | 18 |
| or labeling of a
controlled substance:
| 19 |
| (a) as an incident to his administering or | 20 |
| dispensing of a
controlled substance in the course of | 21 |
| his professional practice; or
| 22 |
| (b) as an incident to lawful research, teaching or | 23 |
| chemical
analysis and not for sale.
| 24 |
| (z-1) (Blank).
| 25 |
| (aa) "Narcotic drug" means any of the following, whether | 26 |
| produced
directly or indirectly by extraction from substances |
|
|
|
09500HB1366ham001 |
- 16 - |
LRB095 04320 RAS 33506 a |
|
| 1 |
| of natural origin,
or independently by means of chemical | 2 |
| synthesis, or by a combination of
extraction and chemical | 3 |
| synthesis:
| 4 |
| (1) opium and opiate, and any salt, compound, | 5 |
| derivative, or
preparation of opium or opiate;
| 6 |
| (2) any salt, compound, isomer, derivative, or | 7 |
| preparation thereof
which is chemically equivalent or | 8 |
| identical with any of the substances
referred to in clause | 9 |
| (1), but not including the isoquinoline alkaloids
of opium;
| 10 |
| (3) opium poppy and poppy straw;
| 11 |
| (4) coca leaves and any salts, compound, isomer, salt | 12 |
| of an isomer,
derivative, or preparation of coca leaves | 13 |
| including cocaine or ecgonine,
and any salt, compound, | 14 |
| isomer, derivative, or preparation thereof which is
| 15 |
| chemically equivalent or identical with any of these | 16 |
| substances, but not
including decocainized coca leaves or | 17 |
| extractions of coca leaves which do
not contain cocaine or | 18 |
| ecgonine (for the purpose of this paragraph, the
term | 19 |
| "isomer" includes optical, positional and geometric | 20 |
| isomers).
| 21 |
| (bb) "Nurse" means a registered nurse licensed under the
| 22 |
| Nursing and Advanced Practice Nursing Act.
| 23 |
| (cc) (Blank).
| 24 |
| (dd) "Opiate" means any substance having an addiction | 25 |
| forming or
addiction sustaining liability similar to morphine | 26 |
| or being capable of
conversion into a drug having addiction |
|
|
|
09500HB1366ham001 |
- 17 - |
LRB095 04320 RAS 33506 a |
|
| 1 |
| forming or addiction sustaining
liability.
| 2 |
| (ee) "Opium poppy" means the plant of the species Papaver
| 3 |
| somniferum L., except its seeds.
| 4 |
| (ff) "Parole and Pardon Board" means the Parole and Pardon | 5 |
| Board of
the State of Illinois or its successor agency.
| 6 |
| (gg) "Person" means any individual, corporation, | 7 |
| mail-order pharmacy,
government or governmental subdivision or | 8 |
| agency, business trust, estate,
trust, partnership or | 9 |
| association, or any other entity.
| 10 |
| (hh) "Pharmacist" means any person who holds a certificate | 11 |
| of
registration as a registered pharmacist, a local registered | 12 |
| pharmacist
or a registered assistant pharmacist under the | 13 |
| Pharmacy Practice Act of 1987.
| 14 |
| (ii) "Pharmacy" means any store, ship or other place in | 15 |
| which
pharmacy is authorized to be practiced under the Pharmacy | 16 |
| Practice Act of 1987.
| 17 |
| (jj) "Poppy straw" means all parts, except the seeds, of | 18 |
| the opium
poppy, after mowing.
| 19 |
| (kk) "Practitioner" means a physician licensed to practice | 20 |
| medicine in all
its branches, dentist, optometrist,
| 21 |
| podiatrist,
veterinarian, scientific investigator, pharmacist, | 22 |
| physician assistant,
advanced practice nurse,
licensed | 23 |
| practical
nurse, registered nurse, hospital, laboratory, or | 24 |
| pharmacy, or other
person licensed, registered, or otherwise | 25 |
| lawfully permitted by the
United States or this State to | 26 |
| distribute, dispense, conduct research
with respect to, |
|
|
|
09500HB1366ham001 |
- 18 - |
LRB095 04320 RAS 33506 a |
|
| 1 |
| administer or use in teaching or chemical analysis, a
| 2 |
| controlled substance in the course of professional practice or | 3 |
| research.
| 4 |
| (ll) "Pre-printed prescription" means a written | 5 |
| prescription upon which
the designated drug has been indicated | 6 |
| prior to the time of issuance.
| 7 |
| (mm) "Prescriber" means a physician licensed to practice | 8 |
| medicine in all
its branches, dentist, optometrist, podiatrist | 9 |
| or
veterinarian who issues a prescription, a physician | 10 |
| assistant who
issues a
prescription for a Schedule III, IV, or | 11 |
| V controlled substance
in accordance
with Section 303.05 and | 12 |
| the written guidelines required under Section 7.5
of the
| 13 |
| Physician Assistant Practice Act of 1987, or an advanced | 14 |
| practice
nurse with prescriptive authority in accordance with | 15 |
| Section 303.05
and a written
collaborative agreement under | 16 |
| Sections 15-15 and 15-20 of
the Nursing and Advanced Practice | 17 |
| Nursing Act.
| 18 |
| (nn) "Prescription" means a lawful written, facsimile, or | 19 |
| verbal order
of
a physician licensed to practice medicine in | 20 |
| all its branches,
dentist, podiatrist or veterinarian for any | 21 |
| controlled
substance, of an optometrist for a Schedule III, IV, | 22 |
| or V controlled substance in accordance with Section 15.1 of | 23 |
| the Illinois Optometric Practice Act of 1987, of a physician | 24 |
| assistant for a Schedule III, IV, or V
controlled substance
in | 25 |
| accordance with Section 303.05 and the written guidelines | 26 |
| required under
Section 7.5 of the
Physician Assistant Practice |
|
|
|
09500HB1366ham001 |
- 19 - |
LRB095 04320 RAS 33506 a |
|
| 1 |
| Act of 1987, or of an advanced practice
nurse who issues a | 2 |
| prescription for a Schedule III, IV, or V
controlled substance | 3 |
| in accordance
with
Section 303.05 and a written collaborative | 4 |
| agreement under Sections 15-15
and
15-20 of the Nursing and | 5 |
| Advanced Practice Nursing Act.
| 6 |
| (oo) "Production" or "produce" means manufacture, | 7 |
| planting,
cultivating, growing, or harvesting of a controlled | 8 |
| substance other than methamphetamine.
| 9 |
| (pp) "Registrant" means every person who is required to | 10 |
| register
under Section 302 of this Act.
| 11 |
| (qq) "Registry number" means the number assigned to each | 12 |
| person
authorized to handle controlled substances under the | 13 |
| laws of the United
States and of this State.
| 14 |
| (rr) "State" includes the State of Illinois and any state, | 15 |
| district,
commonwealth, territory, insular possession thereof, | 16 |
| and any area
subject to the legal authority of the United | 17 |
| States of America.
| 18 |
| (ss) "Ultimate user" means a person who lawfully possesses | 19 |
| a
controlled substance for his own use or for the use of a | 20 |
| member of his
household or for administering to an animal owned | 21 |
| by him or by a member
of his household.
| 22 |
| (Source: P.A. 93-596, eff. 8-26-03; 93-626, eff. 12-23-03; | 23 |
| 94-556, eff. 9-11-05.)
| 24 |
| (720 ILCS 570/103) (from Ch. 56 1/2, par. 1103)
| 25 |
| Sec. 103. Scope of Act. Nothing in this Act limits the |
|
|
|
09500HB1366ham001 |
- 20 - |
LRB095 04320 RAS 33506 a |
|
| 1 |
| lawful authority
granted by the
Medical Practice Act of 1987, | 2 |
| the Nursing and Advanced Practice
Nursing Act, the Illinois | 3 |
| Optometric Practice Act of 1987, or
the Pharmacy Practice Act | 4 |
| of 1987.
| 5 |
| (Source: P.A. 90-742, eff. 8-13-98.)".
|
|